Clinical Trial Update: Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MR-guided high intensity focused ultrasound for uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyoma

Snippet

Sponsor: Thunder Bay Regional Health Research Institute | Conditions: Uterine Leiomyoma | Phase 3 | Status: WITHDRAWN